VANI
Vivani Medical, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
—
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Vivani Medical, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
—
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No other changes.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; no measured co-movers for Vivani Medical, Inc..
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; no measured co-movers for Vivani Medical, Inc..
Annual filing, covered
10-K parsed · Mar 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Tall tick = annual report · Source: EDGAR
No thesis.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Vivani Medical, Inc.
1.06
Expected move
No implied move.
—
—
| Manager | Value | % base | |
|---|---|---|---|
| Vanguardindex-like | $2.2M | 33.90% | +15.49% |
| Tanager Wealth | $753,022 | 11.64% | −5.27% |
| Geodeindex-like | $728,911 | 11.27% | −2.14% |
| Tudor Investment Corp ET AL | $509,518 | 7.88% | −3.61% |
| Commonwealth Equity Services | $409,900 | 6.34% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| Vanguardindex-like | $2.2M | 33.90% | +15.49% |
| Tanager Wealth | $753,022 | 11.64% | −5.27% |
| Geodeindex-like | $728,911 | 11.27% | −2.14% |
| Tudor Investment Corp ET AL | $509,518 | 7.88% | −3.61% |
| Commonwealth Equity Services | $409,900 | 6.34% | 0.00% |
Bull1
Bear2